These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9263656

  • 21. The current state of antiplatelet therapy in acute coronary syndromes: the data and the real world.
    Alexander JH.
    Cleve Clin J Med; 2009 Apr; 76 Suppl 1():S16-23. PubMed ID: 19332589
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
    Rajagopal V, Bhatt DL.
    Semin Thromb Hemost; 2004 Dec; 30(6):649-55. PubMed ID: 15630671
    [Abstract] [Full Text] [Related]

  • 24. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH.
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Low-molecular-weight heparins and glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
    Ferguson J.
    J Invasive Cardiol; 2004 Mar; 16(3):136-44. PubMed ID: 15152164
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes.
    Fitchett D, Goodman SG, Gupta M, Langer A.
    Can J Cardiol; 2002 Nov; 18(11):1179-90. PubMed ID: 12464982
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Management of patients with acute coronary syndromes: what is the clinical role of direct thrombin inhibitors?
    Eikelboom JW, French J.
    Drugs; 2002 Nov; 62(13):1839-52. PubMed ID: 12215055
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition.
    Ferguson JJ, Waly HM, Wilson JM.
    Am Heart J; 1998 Apr; 135(4):S35-42. PubMed ID: 9539494
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Facilitating optimal care of acute coronary, cerebrovascular and peripheral vascular syndromes in the emergency department: the role of oral antiplatelet therapy.
    Volturo GA, Aghababian RV.
    J Thromb Thrombolysis; 2004 Feb; 17(1):29-34. PubMed ID: 15277785
    [Abstract] [Full Text] [Related]

  • 39. Prothrombotic and antithrombotic pathways in acute coronary syndromes.
    Selwyn AP.
    Am J Cardiol; 2003 Jun 19; 91(12A):3H-11H. PubMed ID: 12818729
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.